Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Speciality Chemicals
MomentumDeep Value

Top Speciality Chemicals Stocks India (Week of May 10, 2026)

Active
Expanding
Speciality Chemicals sector as of May 10, 2026: 8 stocks outperforming Nifty 500 · RS +22.5% · 12w streak · breadth expanding

Weekly momentum analysis for Speciality Chemicals sector stocks outperforming Nifty 500.

12-Week Breadth Trend

Stocks in Speciality Chemicals outperforming Nifty 500 by 10%+ over 3 months. Rising trend = broader participation.

Loading chart...

What's Happening in Speciality Chemicals?

8
Stocks Beating Nifty
+1
vs Last Week
12w
Streak
🏆

Sector in Leaders quadrant — broad participation + rising strength.

📈

Breadth expanding — 1 more stock joined this week. More participation = stronger trend.

🔄

Re-entry after absence: Anupam Rasayan India Ltd, Vishnu Chemicals Ltd, DMCC Speciality Chemicals Ltd

🚀

1 stock accelerating — profit growth speeding up: Aether Industries Ltd

🔄

1 turnaround: Tatva Chintan Pharma Chem Ltd

⏳

2 stocks slowing down — profit growth decelerating.

⚠️

3 stocks flagged for margin pressure — profits may not sustain.

⚠️

4 of 6 stocks trading above fair value — limited margin of safety.

📊

Operating margins volatile across 6 stocks — earnings quality uneven, watch for stabilization.

🔥

12-week streak — sustained leadership.

Fundamentals Quality

Based on: Profit Growth, Margins, Cash Flow, Valuations

35
Avg Score
1 Average7 Weak

Only 0% have strong fundamentals — momentum without quality, higher risk.

↑
Sector Verdict
BULLISH

The sector is experiencing a clear operating_leverage_inflection as capacity utilization peaks, driving margin expansion despite commodity and geopolitical risks. Aggressive capex plans and a shift toward value-added products signal long-term confidence.

Top Performers
  • AETHER — Delivered 44% YoY revenue growth and expanded EBITDA margins to 34%, driven by a favorable mix shift toward CRAMS.
  • PRIVISCL — Achieved 86.4% YoY PAT growth and maintained 25.8% EBITDA margins on the back of operational efficiencies.
Laggards
  • NEOGEN — Reported a muted PAT of just ₹4 crore due to high interest expenses and transitionary costs from plant reconstruction.
Catalysts Playing Out
HIGH
Operating Leverage Inflection
4 stocks · AARTIIND, AETHER, PRIVISCL, VISHNU

Higher capacity utilization is driving fixed-cost absorption across the board. VISHNU reported operating levels over 90%, while PRIVISCL is at 85% to 90% utilization.

HIGH
Geographical Expansion
3 stocks · AARTIIND, PRIVISCL, VISHNU

Companies are aggressively diversifying exports to mitigate risks. AARTIIND reached a record 65% export share, and PRIVISCL noted a clear cut advantage over China due to 18% duties.

HIGH
Regulatory Approval Or License Win
2 stocks · AARTIIND, NEOGEN

Tariff reductions and customer approvals are unlocking new markets. NEOGEN secured long-term commercial supply approval following successful PPAP completion.

MEDIUM
Mandatory Industry Norms
1 stock · NEOGEN

Regulatory shifts are forcing supply chain realignments. NEOGEN benefits from US 45X Tax Credits requiring a complete transition to non-FEOC suppliers by 2027.

MEDIUM
Value Added Product Mix Shift
1 stock · VISHNU

Shifting to specialty chemicals is expanding gross margins. VISHNU saw a 170 bps gross margin expansion driven by products like Strontium Carbonate.

Shared Risks
HIGH
Commodity
Affected: AARTIIND, AETHER, NEOGEN, PRIVISCL, VISHNU

Volatility in raw material pricing (lithium, chrome ore, GTO) is pressuring margins.

Mitigation: Backward integration, strategic sourcing, and shifting mix to CRAMS.

HIGH
Geopolitical
Affected: AARTIIND, NEOGEN, PRIVISCL, VISHNU

Tariff-related uncertainties and global trade barriers are impacting sentiment.

Mitigation: Diversifying export mix and positioning as non-FEOC alternatives.

MEDIUM
Labor
Affected: AARTIIND, AETHER

Scarcity of skilled chemistry talent and new labor code implementations are increasing costs.

Mitigation: Implementing ESOPs and provisioning for one-time expenses.

Sector-Aggregate Metrics
EBITDA Margin Range
13% to 34%
Range: Low: 13% (AARTIIND), High: 34% (AETHER)
3 of 5 above 20% margin

Margins are expanding as companies shift toward value-added products and CRAMS.

Capex Commitments
₹300 Cr to ₹1,500 Cr
Range: Low: ₹300 Cr (VISHNU), High: ₹1,500 Cr (NEOGEN)
4 of 5 have capex >= ₹1,000 Cr

The sector is undergoing a massive capacity expansion phase to capture import substitution and China+1 opportunities.

YoY Revenue Growth
9% to 44%
Range: Low: 9% (NEOGEN), High: 44% (AETHER)
3 of 4 reported double-digit YoY growth

Top-line growth remains resilient despite global macroeconomic softness.

Capacity Utilisation Range
80% to >90%
Range: Low: 80% target (NEOGEN), High: >90% (VISHNU)
2 of 3 operating at or above 85%

High utilization rates are driving operating leverage and fixed-cost absorption across the sector.

Cross-Stock Convergence
  • Operating Leverage Inflection
  • Geographical Expansion
  • Regulatory Approval Or License Win

🤖 AI Research Summary

Sector Pulse

The Speciality Chemicals sector is demonstrating a clear recovery trajectory, with 3 of 5 constituents reporting an IMPROVING demand environment. AETHER led the pack with 44% YoY revenue growth, while PRIVISCL delivered an 86.4% YoY surge in PAT. Despite a MIXED global macro backdrop noted by VISHNU and PRIVISCL, aggregate YoY revenue growth ranged from 9% (NEOGEN) to 44% (AETHER).

Catalysts Playing Out Across the Pack

The dominant theme is Operating Leverage Inflection. With capacity utilization hitting 85% to 90% at PRIVISCL and over 90% at VISHNU, fixed-cost absorption is driving margin expansion. Additionally, Geographical Expansion is accelerating as companies capitalize on tariff shifts; AARTIIND reported a record 65% export share, and PRIVISCL highlighted an 18% duty advantage over China.

What Managements Are Guiding

Forward guidance is uniformly CONFIDENT, backed by heavy capital commitments. AARTIIND raised its FY26 capex to Rs. 1,100 crore, and AETHER increased its Site 5 total capex to ₹2,200-2,300 crore. Margin aspirations are equally elevated, with AETHER targeting 29% to 30% and VISHNU aiming for 20% by FY28.

Sub-Sector Aggregates

Analyzing the aggregates reveals a sector in heavy expansion mode. The Capex Commitments range from ₹300 crore (VISHNU) to ₹1,500 crore (NEOGEN), with 4 of 5 constituents committing over ₹1,000 crore. The Ebitda Margin Range spans 13% (AARTIIND) to 34% (AETHER), with 3 of 5 constituents operating above the 20% threshold. Furthermore, the Capacity Utilisation Range of 80% to >90% confirms that existing assets are sweating efficiently.

Shared Risks (9-type taxonomy)

The sector faces elevated commodity and geopolitical risks. All 5 constituents flagged raw material volatility, from lithium prices at NEOGEN to chrome ore at VISHNU. Geopolitical tariff uncertainties were cited by 4 constituents, though companies are mitigating this via export diversification. labor risks are also emerging, with AETHER noting a scarcity of scale-up chemistry skills and AARTIIND taking a Rs. 15 crore hit for new labor code implementations.

Bottom Line

The sector is successfully navigating raw material volatility through backward integration and a shift toward value-added products. With massive capex cycles underway and operating leverage kicking in, the earnings growth trajectory appears highly visible.

Last updated Apr 19, 2026

Top Speciality Chemicals Stocks Beating Nifty 500

8 stocks sorted by market cap. Fundamentals = quality rating + growth flag. Hover for details.

List of stocks outperforming Nifty 500 with fundamental grades and metrics
Stock?Mkt Cap?Status?Valuation?Weeks Outperforming Nifty 500?
Aarti Industries Ltd
17.6K CrSignificantly Overvalued
Aether Industries Ltd
16.1K CrSignificantly Overvalued
Anupam Rasayan India Ltd
15.6K CrRE-ENTRY (2w)Significantly Overvalued
Privi Speciality Chemicals Ltd
13.6K CrSlightly Undervalued
Neogen Chemicals Ltd
4.9K CrNEW THIS MTHSignificantly Overvalued
Vishnu Chemicals Ltd
4.0K CrRE-ENTRY (3w)Slightly Undervalued
Tatva Chintan Pharma Chem Ltd
3.2K CrNEW THIS MTHNo Data
DMCC Speciality Chemicals Ltd
799 CrRE-ENTRY (2w)No Data

Company Comparison

Explore More Sectors

All Expanding SectorsAll Contracting SectorsNew Sectors This Week← Back to Dashboard

Frequently Asked Questions: Speciality Chemicals

Based on publicly available financial data. This is educational research, not investment advice.

Which Speciality Chemicals stocks are worth studying in India?

Based on valuation and growth signals, these Speciality Chemicals stocks show the strongest research merit

  • Privi Speciality Chemicals Ltd — Slightly Undervalued, PAT growth +70.5% YoY, earnings stable
  • Vishnu Chemicals Ltd — Slightly Undervalued, PAT growth 0.0% YoY, earnings stable
  • Aether Industries Ltd — Significantly Overvalued, PAT growth +48.8% YoY, earnings decelerating
  • Anupam Rasayan India Ltd — Significantly Overvalued, PAT growth +13.0% YoY, earnings stable
  • DMCC Speciality Chemicals Ltd — Significantly Overvalued, PAT growth -21.6% YoY, earnings inflecting downward
  • Stocks sorted by valuation signal (most undervalued first).

How many Speciality Chemicals stocks are outperforming Nifty 500?

Currently, 8 stocks in the Speciality Chemicals sector are outperforming Nifty 500. This represents the sector's breadth — a higher count indicates broader sector participation in the market rally.

Is Speciality Chemicals expanding or contracting this week?

The Speciality Chemicals sector is expanding this week with a breadth change of +1 stocks.

Which Speciality Chemicals stocks have the highest revenue growth?

The Speciality Chemicals stocks with the highest revenue growth

  • Tatva Chintan Pharma Chem Ltd — Revenue growth +52.3% YoY
  • Aether Industries Ltd — Revenue growth +44.1% YoY
  • Anupam Rasayan India Ltd — Revenue growth +31.3% YoY
  • DMCC Speciality Chemicals Ltd — Revenue growth +27.8% YoY
  • Aarti Industries Ltd — Revenue growth +25.8% YoY

Which Speciality Chemicals stocks have the highest profit growth?

The Speciality Chemicals stocks with the highest profit growth

  • Aarti Industries Ltd — PAT growth +189.1% YoY
  • Privi Speciality Chemicals Ltd — PAT growth +70.5% YoY
  • Aether Industries Ltd — PAT growth +48.8% YoY
  • Anupam Rasayan India Ltd — PAT growth +13.0% YoY
  • Vishnu Chemicals Ltd — PAT growth 0.0% YoY

What is the average PE ratio of Speciality Chemicals stocks?

The average PE ratio of Speciality Chemicals stocks with available data is 67.6x. This provides a benchmark for comparing individual stock valuations within the sector.

What is the earnings trend across Speciality Chemicals?

Earnings trend breakdown across Speciality Chemicals (8 stocks with data)

  • 1 stocks with decelerating earnings
  • 2 stocks showing turnaround signals
  • 5 stocks with stable earnings

Is Speciality Chemicals a good sector to study for long term?

Speciality Chemicals shows mixed but improving signals — some stocks have strong fundamentals, worth selective study.

  • Fundamentals: 0 of 8 stocks rated Very Strong/Strong, 1 Average, 7 Weak/Very Weak
  • Profit growth: 4 stocks with PAT growing YoY, 2 declining
  • Revenue growth: 8 of 8 stocks with positive revenue growth YoY

Are there any turnaround stories in Speciality Chemicals?

2 stocks in Speciality Chemicals are showing turnaround signals — earnings inflecting upward after a period of decline

  • Aarti Industries Ltd — PAT growth +189.1% YoY (inflection up)
  • Tatva Chintan Pharma Chem Ltd — PAT growth N/A YoY (inflection up)

Which Speciality Chemicals stocks have the longest outperformance streak?

Speciality Chemicals stocks with the longest outperformance streaks

  • Aarti Industries Ltd — 12 weeks consecutive outperformance, PAT growth +189.1% YoY, Revenue +25.8% YoY
  • Aether Industries Ltd — 12 weeks consecutive outperformance, PAT growth +48.8% YoY, Revenue +44.1% YoY
  • Privi Speciality Chemicals Ltd — 6 weeks consecutive outperformance, PAT growth +70.5% YoY, Revenue +23.2% YoY
  • Neogen Chemicals Ltd — 4 weeks consecutive outperformance, PAT growth -63.1% YoY, Revenue +9.2% YoY
  • Vishnu Chemicals Ltd — 4 weeks consecutive outperformance, PAT growth 0.0% YoY, Revenue +10.8% YoY

What is the Speciality Chemicals breadth trend over the last 12 weeks?

Speciality Chemicals breadth trend over recent weeks

  • Apr 3: 4 stocks outperforming
  • Apr 11: 3 stocks outperforming
  • Apr 18: 6 stocks outperforming
  • Apr 24: 7 stocks outperforming
  • May 2: 7 stocks outperforming
  • May 10: 8 stocks outperforming

What is happening in Speciality Chemicals right now?

Here is the current fundamental and growth snapshot for Speciality Chemicals

  • Fundamentals: 0 of 8 stocks rated Very Strong or Strong, 7 rated Weak or Very Weak
  • Profit trend: 4 stocks with PAT growing YoY, 2 with profits declining
  • Revenue trend: 8 stocks growing revenue, 0 seeing revenue decline
  • Market breadth: 8 stocks currently outperforming Nifty 500

The above FAQs are based on publicly available market data and financial metrics. This is educational research only for learning about sector and stock performance. Sector Alpha is not SEBI registered and does not provide investment advice or buy/sell recommendations.